Background Endometrial cancer is the most common gynecologic malignancy in developed countries. Trop-2 is a glycoprotein involved in cellular signal transduction and is differentially ...
Hosted on MSN8mon
IDEAYA Biosciences Highlights 'Encouraging' Preliminary Efficacy, Safety Profile For Patients With Hard-To-Treat Cancerincluding with Amgen’s investigational MTA-cooperative protein arginine methytranferase 5 inhibitor AMG 193 in NSCLC and with Gilead’s Trop-2 directed anti-body conjugate Trodelvy in ...
*Because of the small number of events (deaths and progressions) in the G1 EEC category, the confidence interval was not reliable.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback